Arjun Prasad

Arjun Prasad

Chief Commercial Officer

Arjun Prasad is the Chief Commercial Officer at Servier Pharmaceuticals. He is responsible for Sales, Marketing, Market Access, and Commercial Learning & Development activities across the portfolio. The Commercial teams maintain responsibility for ONCASPAR and ASPARLAS in acute lymphoblastic leukemia (ALL) and TIBSOVO and IDHIFA in mIDH1/2+ acute myeloid leukemias (AML), and TIBSOVO in 2L+ cholangiocarcinoma (CCA). Arjun’s team is also responsible for U.S. commercialization of future  products  and indications, including vorasidenib for mIDH adult diffuse gliomas.

Arjun has significant leadership experience across a variety of Commercial roles. Prior to joining Servier Pharmaceuticals, Arjun was at Agios Pharmaceuticals, where he was the Vice President of Global Oncology Marketing, as well as the Vice President of Commercial Operations & Analytics for both the Oncology and Genetically Defined Diseases portfolios. Prior to Agios, Arjun spent almost 12 years at Genentech, where he led various Sales, Marketing and Analytics teams. Arjun has deep experience and a passion for advancing oncology care, having worked across a number of tumor types, including hematologic malignancies, NSCLC, breast cancer, and melanoma. He has also worked on pipeline and marketed products for a variety of cardiometabolic and immunology indications. Arjun brings a strong track record of strategic agility and drive for results to his role, as well as a focus on collaboration across programs ranging from early stage development to marketed products.

Arjun maintains a long-standing commitment to addressing unmet needs and delivering clinical value to patients. Early in his career he focused on international public health, working as an International Health Officer with the Office of Global Health Affairs at the U.S. Department of Health & Human Services and also as a Public Health volunteer with the U.S. Peace Corps.

Arjun received his Bachelor of Arts from Washington University in St. Louis and a Master in Public Health and Master in Business Administration from Johns Hopkins University.